Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia

被引:11
作者
Basile, Umberto [1 ]
Marino, Mariapaola [2 ]
Gragnani, Laura [3 ,4 ]
Napodano, Cecilia [5 ]
Gulli, Francesca [6 ]
Pocino, Krizia [5 ]
Lorini, Serena [3 ,4 ]
Santini, Stefano Angelo [1 ]
Basile, Valerio [7 ]
Miele, Luca [5 ]
Zignego, Anna Linda [3 ,4 ]
Rapaccini, Gian Ludovico [5 ]
机构
[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Ist Patol Gen, Rome, Italy
[3] AOUC, Interdept Ctr Syst Manifestn Hepatitis Viruses MA, Dept Expt & Clin Med, Florence, Italy
[4] AOUC, Dept Oncol, Florence, Italy
[5] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Med Interna & Gastroenterol, Rome, Italy
[6] Osped Madre Giuseppina Vannini, Dipartimento Med Lab, Rome, Italy
[7] Univ Tor Vergata, Dipartimento Med Lab, Rome, Italy
关键词
Hepatitis C virus; Mixed cryoglobulinemia; Free light chains; Vascular endothelial growth factor; Biomarkers; FREE LIGHT-CHAINS; ENDOTHELIAL GROWTH-FACTOR; VEGF; LYMPHOMA;
D O I
10.1016/j.jim.2019.112687
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Infections, autoimmunity and cancer play a role as determinants of etiology in Hepatitis C virus (HCV) related mixed cryoglobulinemia (MC). Several factors of risk have been suggested as markers of pathogenesis and progression of HCV-related MC into B cell Non-Hodgkin's Lymphoma (B-NHL). Here, we evaluated IgG subclass distribution, free light chains (FLCs) and vascular endothelial growth factor (VEGF) as a new combination of biomarkers. Methods: We measured IgG1-4 subclasses, FLCs and VEGF levels in sera 53 from HCV-related MC, in comparison with 40 sera from HCV negative patients with rheumatoid arthritis (RA) and 30 from healthy blood donors (HBD). Results: IgG3 levels were significantly higher in HCV-MC patients with a decrement of IgG2 and IgG4; FLC levels significantly increased in both MC and RA patients' groups; serological VEGF was higher in HCV-MC patients than in HBD in correlation with k and lambda levels. Conclusion: Our results suggest that a specific IgG subclasses pattern together with raised levels of FLCs and VEGF could represent the biomarker "signature" of an inflammation multistage of acquired immune system.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia
    Basile, Umberto
    Gulli, Francesca
    Napodano, Cecilia
    Pocino, Krizia
    Basile, Valerio
    Marrapodi, Ramona
    Colantuono, Stefania
    Todi, Laura
    Marino, Mariapaola
    Rapaccini, Gian Ludovico
    Visentini, Marcella
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2021, 68 (02) : 319 - 329
  • [2] Biomarkers in HCV-related mixed cryoglobulinemia patients with non-Hodgkin lymphoma
    Gulli, F.
    Marino, M.
    Napodano, C.
    Pocino, K.
    Pandolfi, F.
    Gasbarrini, A.
    Rapaccini, G. L.
    Basile, U.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (15) : 8067 - 8074
  • [3] Treatment of HCV-Related Mixed Cryoglobulinemia
    Giuggioli, Dilia
    Sebastiani, Marco
    Colaci, Michele
    Fallahi, Poupak
    Gragnani, Laura
    Zignego, Anna Linda
    Antonelli, Alessandro
    Ferri, Clodoveo
    CURRENT DRUG TARGETS, 2017, 18 (07) : 794 - 802
  • [4] Thyroid cancer in HCV-related mixed cryoglobulinemia patients
    Antonelli, A
    Ferri, C
    Fallahi, P
    Nesti, C
    Zignego, AL
    Maccheroni, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (05) : 693 - 696
  • [5] No Evidence of Polyomavirus and EBV Infections in Italian Patients with Mixed Cryoglobulinemia Infected Chronically with HCV
    Comar, Manola
    Zanotta, Nunzia
    Del Savio, Rossella
    Vascotto, Fulvia
    Calabrese, Nadia
    Zorat, Francesca
    Pozzato, Gabriele
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (04) : 666 - 671
  • [6] Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients
    Basile, Umberto
    Gulli, Francesca
    Gragnani, Laura
    Pocino, Krizia
    Napodano, Cecilia
    Miele, Luca
    Santini, Stefano Angelo
    Marino, Mariapaola
    Zignego, Anna Linda
    Rapaccini, Gian Ludovico
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (09) : 938 - 943
  • [7] Effectiveness of leukocyte interferon in patients affected by HCV-positive mixed cryoglobulinemia resistant to recombinant alpha-interferon
    Mazzaro, C
    Colle, R
    Baracetti, S
    Nascimben, F
    Zorat, F
    Pozzato, G
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (01) : 27 - 34
  • [8] Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment
    Stasi, Cristina
    Triboli, Elisa
    Arena, Umberto
    Urraro, Teresa
    Petrarca, Antonio
    Gragnani, Laura
    Laffi, Giacomo
    Zignego, Anna Linda
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [9] How HCV has changed the approach to mixed cryoglobulinemia
    Della Rossa, A.
    Baldini, C.
    Tavoni, A.
    Bombardieri, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (01) : S115 - S123
  • [10] Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients
    Kosmas, Nikolaos
    Kontos, Athanasios
    Panayiotakopoulos, George
    Dimitrakopoulos, Antonios
    Kordossis, Theodore
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (10) : 1257 - 1261